Carcangiu M L, Bianchi S, Savino D, Voynick I M, Rosai J
Department of Pathology, Yale University School of Medicine, New Haven, CT 06510.
Cancer. 1991 Nov 1;68(9):1944-53. doi: 10.1002/1097-0142(19911101)68:9<1944::aid-cncr2820680917>3.0.co;2-i.
A clinicopathologic study of 153 cases of thyroid follicular Hurthle cell tumor (HCT) is presented. Follow-up, available in all cases, ranged from 5 to 26 years (median, 9 years). These neoplasms were divided into three categories on the basis of presence and degree of capsular and vascular invasion, pattern of growth (follicular, trabecular, or solid), nuclear atypia, and necrosis. The categories were benign (90 cases), indeterminate (35 cases), and malignant (28 cases). All the tumors classified histologically as benign or indeterminate behaved in a clinically benign fashion. Of the 28 tumors classified histologically as malignant, 20 had a clinically malignant behavior. At survival analysis, no clinical or pathologic feature among the carcinomas was found to correlate with a fatal outcome. It is concluded that histologic criteria alone can distinguish benign from malignant HCT and that clinical or pathologic feature cannot predict behavior among the malignant tumors.
本文报告了153例甲状腺滤泡性许特莱细胞肿瘤(HCT)的临床病理研究。所有病例均有随访,随访时间为5至26年(中位时间为9年)。这些肿瘤根据包膜和血管侵犯的有无及程度、生长模式(滤泡性、小梁状或实性)、核异型性和坏死情况分为三类。分类为良性(90例)、不确定(35例)和恶性(28例)。所有组织学分类为良性或不确定的肿瘤临床行为均为良性。在28例组织学分类为恶性的肿瘤中,20例临床行为为恶性。生存分析显示,癌的临床或病理特征与致命结局均无相关性。结论是,仅组织学标准就能区分良性和恶性HCT,而临床或病理特征无法预测恶性肿瘤的行为。